Educaciòn Médica Continuada CME. Créditos Disponibles WAO

Vamos  a presentar  Gloria  una  organizaciòn  que  colabora  con  la  Organizaciòn  Mundial  de  Alergia  WAO,  encargada  de mantenernos  al  día,  con los avances  científicos  de la Alergia  y  la  Inmunología.

Representantes de los  cinco  continentes  se  destacan:

Members of the International GLORIA faculty represent the five major continents and collaborate closely with WAO Regional Affiliate Organizations and WAO National Member Societies in their regions to keep up-to-date on the latest advances in the field of allergy and immunology.  

   2012-2013 International GLORIA Advisory Board

Ruby Pawankar, Japan	Sandra González-Díaz, Mexico
Stephen T. Holgate, United Kingdom	Tari Haahtela, Finland
Mario Sánchez Borges, Venezuela	Elham Hossny (Ex-Officio), Egypt
Lanny J. Rosenwasser, United States	Juan Carlos Ivancevich, Argentina
Richard F. Lockey, United States	Francesca Levi-Schaffer, Israel
G. Walter Canonica, Italy	Susan Prescott, Australia
Ignacio Ansotegui, Spain	Marek L. Kowalski, Poland
Claus Bachert, Belgium	Nelson Rosario-Filho, Brazil
Michael Blaiss, United States	Hugh Sampson, United States
Motohiro Ebisawa, Japan	Tatiana Slavyanskaya, Russia
Roy Gerth van Wijk, Netherlands	Dana Wallace, United States

He  escogido  para  el  post  de  hoy, las  magistrales presentaciones
Alergia  a  Medicamentos  (  Drug allergy).

Slides (Part 1)    Slides (Part 2)

This 2 part slide set covers definitions, epidemiology, risk factors, clinical manifestations with reference to pathogenesis/mechanisms, specific classes of drugs, diagnosis, treatment, desensitization and prevention.

Upon completion of Part 1 of this program, participants should be able to:

• Understand the difference between
  • Adverse drug reaction
  • Drug hypersensitivity
  • Drug allergy
• 
  
• Understand the epidemiology and risk factors for drug allergy
• Understand the pathogenesis and immunological mechanisms underlying the different phenotypes of drug allergy

Upon completion of Part 2 of this program, participants should be able to:

• Understand the clinical features of drug allergy in relation to the underlying pathogenetic mechanisms
• Understand the principles in the clinical diagnosis of drug allergy
• Understand the principles of diagnostic and provocation tests
• Manage drug allergies

Slide content revised January 2009; slide format updated June 2011

Quizás le  interese  las  actividades  de  Educación  Médica  Continuada Créditos  disponibles  de la  WAO.

•  1er.Modulo     Alergia  a  Medicamentos  ( Drug  Allergy ):

   Overview

   Learning Objectives
  
  

  Case Study

•  Section 1 - Drug HypersensitivityLesson
•  Section 2 - Latent SyphilisLesson
•  Section 3 - Allergy to PenicillinsLesson
•  Section 4 - Allergy to CephalosporinsLesson
•  Section 5 - Case historyLesson
•  Section 6 - EvolutionLesson
•  Section 7 - Desensitization.

• Test - Required for CME

•  Final ExamQuiz

• Certificate and Evaluation - Required for CME

•  Certificate of Completion - Drug Allergy: WAO Online Learning Program & CME
•  Activity Evaluation - Please complete before leaving.

Regresaremos  con  el  material de los  modulos  II y  III.

Desde  Nicaragua.

Clínica  de  Asma  y Alergia

Dr. Juan Herrera  Salazar.